Showing results (31-40 of 38) with videos related to
Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 38 results.
Oral Oncology|July 27, 2019
Lack of efficacy of neoadjuvant chemotherapy in adult patients with maxillo-facial high-grade osteosarcomas: A French experience in two reference centersJebrane Bouaoud, Guillaume Beinse, Nicolas Epaillard, et al.Cancers|April 12, 2022
Unmet Needs and Perspectives in Oral Cancer PreventionJebrane Bouaoud, Paolo Bossi, Moshe Elkabets, et al.Iscience|May 26, 2020
CDYL2 Epigenetically Regulates MIR124 to Control NF-κB/STAT3-Dependent Breast Cancer Cell PlasticityMaha Siouda, Audrey D Dujardin, Laetitia Barbollat-Boutrand, et al.Cancer Medicine|November 19, 2018
Ewing's Sarcoma of the Head and Neck: Margins are not just for surgeonsJebrane Bouaoud, Stephane Temam, Nathalie Cozic, et al.Journal of Stomatology, Oral and Maxillofacial Surgery|August 17, 2021
In-house 3D printing: Why, when, and how? Overview of the national French good practice guidelines for in-house 3D-printing in maxillo-facial surgery, stomatology, and oral surgeryRoman Hossein Khonsari, Jeremy Adam, Mourad Benassarou, et al.European Journal of Cancer (Oxford, England : 1990)|August 29, 2022
Immunologically active phenotype by gene expression profiling is associated with clinical benefit from PD-1/PD-L1 inhibitors in real-world head and neck and lung cancer patientsJean-Philippe Foy, Andy Karabajakian, Sandra Ortiz-Cuaran, et al.Data in Brief|September 16, 2022
Datasets for gene expression profiles of head and neck squamous cell carcinoma and lung cancer treated or not by PD1/PD-L1 inhibitorsJean-Philippe Foy, Andy Karabajakian, Sandra Ortiz-Cuaran, et al.Journal for Immunotherapy of Cancer|March 16, 2022
MEK1/2 inhibition transiently alters the tumor immune microenvironment to enhance immunotherapy efficacy against head and neck cancerManu Prasad, Jonathan Zorea, Sankar Jagadeeshan, et al.Pageof 4